Tags |
|
|
Links |
|
|
E-Articles - Crohn's Disease Symptoms
Crohn’s disease is a condition which causes inflammation of the digestive or gastrointestinal (GI) tract. It can occur anywhere in the GI tract; but is pr
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
edominant in the lower part of the small intestine, in the ileum. This swelling reaches the lining of the affected organ to cause pain and leads to the fr
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
equent emptying of intestines to lead to diarrhea.
Crohn’s disease is referred by different names depending on the inflammation that occurs in different
Crohn’s disease is referred by different names depending on the inflammation that occurs in different
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
parts of the intestine. Inflammation that is found in the end of the small intestine is referred to as Crohn’s terminal ileitis and Crohn’s entero-coiliti
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
s and ileo-colitis are the terms used to describe the inflammation of the small intestine and colon. In both cases of Crohn’s disease, a small intestinal
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
bstruction, diarrhea and abdominal pain are the common symptoms.
As the symptoms of Crohn’s disease are similar to other intestinal disorders, they are d
As the symptoms of Crohn’s disease are similar to other intestinal disorders, they are d
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
ifficult to diagnose. Sufferers usually have all the layers of the intestine involved in the infection where there may also be healthy bowel found in betw
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
een the sections of diseased bowel. The most common symptoms are abdominal pain, rectal bleeding, arthritis, skin problems, fever and sometimes persistent
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
bleeding that leads to anemia.
Crohn’s disease is a life long condition where there are flare ups of the symptoms that tend to alternate with periods of
Crohn’s disease is a life long condition where there are flare ups of the symptoms that tend to alternate with periods of
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
remission. There is no actual trigger for a relapse but when a person suffers from symptoms of Crohn’s disease it indicates that the disease is active.
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
iarrhea that arises from Crohn’s disease may contain blood, pus or mucus that may go up to 10 or 20 times a day, even at night. This may in turn lead to p
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ainful tears or fissures developing around the anus. The pain in the abdomen associated with Crohn’s disease is referred to be cramping or colicky. In suc
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
h cases, the abdomen becomes sore to the touch, and tends to swell up.
Weight loss is another symptom of Crohn’s disease that is a consequence of diarrhe
Weight loss is another symptom of Crohn’s disease that is a consequence of diarrhe
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
a and the loss of appetite a person develops when suffering from Crohn’s disease. Another symptom of Crohn’s disease is mouth ulcers, joint pain, inflamma
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
tion in the eyes and rashes or ulcers that are found on the skin.
A chronic sufferer of Crohn’s disease experiences severe inflammation complications whi
A chronic sufferer of Crohn’s disease experiences severe inflammation complications whi
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
h includes fistula which is an abnormal connection that exists between the bowel and a part near the bowel like the bladder, vagina or loop of bowel. Thes
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
e fistulas can lead to recurrent infections of the urinary genital tracts.
Some people suffer from other complications like abscesses that form inside th
Some people suffer from other complications like abscesses that form inside th
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
e abdomen or perhaps a stricture that tends to obstruct the passage of bowel movements. And a person, who has suffered from Crohn’s disease for eight to t
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
en years, faces an increased risk of getting bowel cancer.
As it can be seen there are numerous symptoms to Crohn’s disease which are similar to a case o
As it can be seen there are numerous symptoms to Crohn’s disease which are similar to a case o
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
f indigestion and piles it is necessary to have a check up with recurrence of the symptoms. This is to prevent complications that may lead to bowel cancer
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.e-article.org.ua/article/241690/e-article-Crohns-Disease-Symptoms.html">Crohn's Disease Symptoms</a>
BB link (for phorums):
[url=http://www.e-article.org.ua/article/241690/e-article-Crohns-Disease-Symptoms.html]Crohn's Disease Symptoms[/url]
Related Articles:
LG U880: Slim, Stylish and Enticing
Dating Tips - The Secrets About Cologne
Bookmark it:
|